One third of all drugs on the American market act on the same kind of important cell receptor — the G protein-coupled receptors. A major mapping of these drugs has found that their pharmacological mechanisms are becoming more complex. The mapping also reveals rapid developments especially within Alzheimer’s disease, obesity, asthma and diabetes.